Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP255352.RAfoxg7UnI6mqi7UvgUYS3vgvBQuA45RMteniuPHOzvsQ130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255352.RAfoxg7UnI6mqi7UvgUYS3vgvBQuA45RMteniuPHOzvsQ130_provenance.
• NP376702.RA0HlJXXBE1LdNoKeykWdP88DQLKO0ghQ9oiL148Oq7o4130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376702.RA0HlJXXBE1LdNoKeykWdP88DQLKO0ghQ9oiL148Oq7o4130_provenance.
• NP783231.RADNDGEvmmtLi-I7Lcq647MRsP7lQVN6TNNV27vK0avAs130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783231.RADNDGEvmmtLi-I7Lcq647MRsP7lQVN6TNNV27vK0avAs130_provenance.
• NP579210.RArREbGdTj-dT6VKv7_TR-R4TRZcTIwh1Tnj7PUR0NOoE130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579210.RArREbGdTj-dT6VKv7_TR-R4TRZcTIwh1Tnj7PUR0NOoE130_provenance.
• NP861661.RARAI1O71nXJvBZBYkG7sPV_czUgVFkxLWx1A5eEcuAaU130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861661.RARAI1O71nXJvBZBYkG7sPV_czUgVFkxLWx1A5eEcuAaU130_provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP300913.RASHj1Rj2AmscBHHEqLrNz414q0KQIvDm7d41-o1jrSfQ130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300913.RASHj1Rj2AmscBHHEqLrNz414q0KQIvDm7d41-o1jrSfQ130_provenance.
• NP810804.RAfbHZPnX923syszKjwkIYXk5tCd3YntNcbIkeLQIYvhM130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810804.RAfbHZPnX923syszKjwkIYXk5tCd3YntNcbIkeLQIYvhM130_provenance.
• NP1001731.RAVi3Hkpk_ZJjVSySVer4QaCLdqwaSfyELIUyaLMIHhSA130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001731.RAVi3Hkpk_ZJjVSySVer4QaCLdqwaSfyELIUyaLMIHhSA130_provenance.
• NP580673.RALhipmatMfDsePiTGe1gtAjzYVRw_wd-c0lkbf1sdnHk130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580673.RALhipmatMfDsePiTGe1gtAjzYVRw_wd-c0lkbf1sdnHk130_provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP899829.RAYZ4q4RkmUdKujWZjE7_Em_NQPo24T-0Jwe9ixPncSio130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899829.RAYZ4q4RkmUdKujWZjE7_Em_NQPo24T-0Jwe9ixPncSio130_provenance.
• NP899833.RARhlr-bNOP64WpuSqMjmMJgt_ZXVO4HlZdNhZqPByj2k130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899833.RARhlr-bNOP64WpuSqMjmMJgt_ZXVO4HlZdNhZqPByj2k130_provenance.
• NP1001713.RACdfnWdt_ximf9XMuVFRuZ7AvkPi-Vx77yndSx1k1m7A130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001713.RACdfnWdt_ximf9XMuVFRuZ7AvkPi-Vx77yndSx1k1m7A130_provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP810754.RAh6q3CAwZVreaNvGKg-LRmqETmbcoIE--J0m73N_mfbo130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810754.RAh6q3CAwZVreaNvGKg-LRmqETmbcoIE--J0m73N_mfbo130_provenance.
• NP899831.RAhE2eMgiS6_grA9nQNT6Qlasi6bV-kNKQmguchLW3TG0130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899831.RAhE2eMgiS6_grA9nQNT6Qlasi6bV-kNKQmguchLW3TG0130_provenance.
• NP899834.RAuyEWYtqMB6_6ePvJkMmPWn9eLKRN3_Mk111NzKPwR30130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899834.RAuyEWYtqMB6_6ePvJkMmPWn9eLKRN3_Mk111NzKPwR30130_provenance.
• NP899836.RAjuCFnFuw9rjHNUhri9P44ccT9l74TwBMzxMKtEQltd8130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899836.RAjuCFnFuw9rjHNUhri9P44ccT9l74TwBMzxMKtEQltd8130_provenance.
• NP300976.RAwMHxfZPSCCadYE11SzQIAqF65HGXDkSudQs-1s31wow130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300976.RAwMHxfZPSCCadYE11SzQIAqF65HGXDkSudQs-1s31wow130_provenance.
• NP300696.RALqdHAFVrPoUvsvIt89IX9De3eI_Q02yfo8pRgb1t3R0130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300696.RALqdHAFVrPoUvsvIt89IX9De3eI_Q02yfo8pRgb1t3R0130_provenance.
• NP899835.RAOl7ZVmGXDTgivWOFyliNP97dWDhwYqXEtY0X1mv49D8130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899835.RAOl7ZVmGXDTgivWOFyliNP97dWDhwYqXEtY0X1mv49D8130_provenance.
• NP810794.RA1bytznT9jn7ECDXoIz8CBAhcBzB7t6WmnsXV2OXXxKk130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810794.RA1bytznT9jn7ECDXoIz8CBAhcBzB7t6WmnsXV2OXXxKk130_provenance.
• NP1001728.RA7j7u_B7voQQDAKVfvrFNK2DlFMPyqDPQVMWtLI1xRWE130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001728.RA7j7u_B7voQQDAKVfvrFNK2DlFMPyqDPQVMWtLI1xRWE130_provenance.
• NP899828.RAzBZTdJipHOVApIF78c-urmkzhO4-CFlETUjWnS_gU4w130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899828.RAzBZTdJipHOVApIF78c-urmkzhO4-CFlETUjWnS_gU4w130_provenance.
• NP899830.RAzASJuUzUQ5YJBv_r_l1CosEDZAz69KDAaLdAoOxIW5k130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899830.RAzASJuUzUQ5YJBv_r_l1CosEDZAz69KDAaLdAoOxIW5k130_provenance.
• NP899832.RA0C-YPIVbTJMvZc9hNYkv5cVCEaQfweyFKSvGV8y614c130_assertion description "[MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899832.RA0C-YPIVbTJMvZc9hNYkv5cVCEaQfweyFKSvGV8y614c130_provenance.